Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jobelyn is a natural dietary supplement derived from the leaf sheath of Sorghum bicolor, an ancient African grain. It is formulated as a potent antioxidant and anti-inflammatory agent with high polyphenol content, particularly anthocyanins and other flavonoids such as apigeninidin. Jobelyn is marketed for its ability to strengthen the immune system, support healthy blood production, improve joint health by inhibiting inflammatory mediators, and provide cellular protection against oxidative stress. Research suggests it may have benefits in conditions like anemia (including in HIV-positive patients), sickle cell disease (by reducing oxidative stress), memory impairment due to chronic stress (via acetylcholinesterase inhibition and reduced corticosterone levels), and potentially psychosis based on animal studies[1][3][4][5]. Its mechanism of action centers on antioxidant activity—scavenging free radicals—and anti-inflammatory effects through cyclooxygenase inhibition[3]. The product is widely used as a nutritional supplement for general wellness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jobelyn.